Table 1

Patient characteristics

T2DM group
RYGBNonsurgical controlP value
No. patients (female/male)12 (10/2)12 (6/6)0.08
Age (years)50.0 ± 2.6750.7 ± 3.290.88
BMI (kg/m2)35.71 ± 0.8437.81 ± 1.380.21
RYGB-induced change in BMI−16.5 ± 1.53
HbA1c (%)5.70 ± 0.167.04 ± 0.370.005
RYGB-induced change in HbA1c−1.37 ± 0.48
Years since diabetes diagnosis11.17 ± 1.916.46 ± 1.090.043
Months since RYGB surgery17.73 ± 2.68
Oral diabetes medication280.005
Insulin therapy020.078
  • Data are mean ± SEM. Medication is given as the number of subjects taking oral medication or undergoing insulin therapy.